Harnessing the power of the immune system to target cancer
- PMID: 23092383
- DOI: 10.1146/annurev-med-112311-083918
Harnessing the power of the immune system to target cancer
Abstract
For many years, immunotherapeutic approaches for cancer held more promise than actual clinical benefit for the majority of patients. However, several recent key advances in tumor immunology have now turned the tide in favor of immunotherapy for the treatment of many different cancer types. In this review, we describe four of the most effective immunotherapeutic approaches currently used in the clinic: cancer vaccines, immunostimulatory agents, adoptive T cell therapy, and immune checkpoint blockade. In addition, we discuss some of the most promising future strategies that aim to utilize multiple immunotherapies or combine them with other approaches to more effectively target cancer.
Similar articles
-
Cancer immunotherapy: the beginning of the end of cancer?BMC Med. 2016 May 5;14:73. doi: 10.1186/s12916-016-0623-5. BMC Med. 2016. PMID: 27151159 Free PMC article. Review.
-
Cell Fate Reprogramming in the Era of Cancer Immunotherapy.Front Immunol. 2021 Jul 21;12:714822. doi: 10.3389/fimmu.2021.714822. eCollection 2021. Front Immunol. 2021. PMID: 34367185 Free PMC article. Review.
-
Immunotherapeutic strategies for cancer treatment: a novel protein transfer approach for cancer vaccine development.Med Res Rev. 2012 Nov;32(6):1197-219. doi: 10.1002/med.20237. Epub 2011 Jan 16. Med Res Rev. 2012. PMID: 23059764 Review.
-
Immunotherapies and Combination Strategies for Immuno-Oncology.Int J Mol Sci. 2020 Jul 15;21(14):5009. doi: 10.3390/ijms21145009. Int J Mol Sci. 2020. PMID: 32679922 Free PMC article. Review.
-
Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon.Cytotherapy. 2018 Oct;20(10):1227-1237. doi: 10.1016/j.jcyt.2018.08.002. Epub 2018 Sep 26. Cytotherapy. 2018. PMID: 30266521 Review.
Cited by
-
A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs.Front Genet. 2022 Sep 21;13:1016449. doi: 10.3389/fgene.2022.1016449. eCollection 2022. Front Genet. 2022. PMID: 36212122 Free PMC article.
-
Oncolytic viruses for cancer immunotherapy.J Hematol Oncol. 2020 Jun 29;13(1):84. doi: 10.1186/s13045-020-00922-1. J Hematol Oncol. 2020. PMID: 32600470 Free PMC article. Review.
-
Structural Prediction of Peptide-MHC Binding Modes.Methods Mol Biol. 2022;2405:245-282. doi: 10.1007/978-1-0716-1855-4_13. Methods Mol Biol. 2022. PMID: 35298818 Review.
-
The mechanical responses of advecting cells in confined flow.Biomicrofluidics. 2020 May 4;14(3):031501. doi: 10.1063/5.0005154. eCollection 2020 May. Biomicrofluidics. 2020. PMID: 32454924 Free PMC article. Review.
-
Human cell-based artificial antigen-presenting cells for cancer immunotherapy.Immunol Rev. 2014 Jan;257(1):191-209. doi: 10.1111/imr.12129. Immunol Rev. 2014. PMID: 24329798 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical